Recent Advances on Treatment of Hodgkin's Lymphoma -Review.
10.7534/j.issn.1009-2137.2016.04.051
- Author:
Yan-Fen LI
1
;
Hai-Yan ZHU
2
,
3
Author Information
1. Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China.
2. Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China.E-mail: 13910020121@
3. com.
- Publication Type:Journal Article
- MeSH:
Hodgkin Disease;
Humans;
Treatment Outcome
- From:
Journal of Experimental Hematology
2016;24(4):1237-1240
- CountryChina
- Language:Chinese
-
Abstract:
Outstanding progress has been achieved in the treatment of Hodgkin's lymphoma in recent years, most of patients can be cured by using modern therapy. However, more and more attentions have been paid on treatment-related complications, the current treatment strategies are focusing on further improving treatment efficacy, while reducing treatment-related toxicity. It is still to be determined whether interim PET imaging could directly judge the therapeutic response so as to make the individualized treatment programs for the patients, for instance through intensifying or abbreviating chemotherapy regimens and/or omitting radiotherapy. The emergence of some novel highly effective targeted drugs might offer hope for the relapsed and refractory patients. In this review, the recent advances on the treatment of Hodgkin's lymphoma are summaried.
